Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 15 | 18 | +3 |
| Shares | 1.51M | 588.9K | −919.1K (−60.9%) |
| Value | $1.13M | $257.0K | −$874.0K (−77.3%) |
New holders (5)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 257,866 | $113.0K | 0.00% |
| Virtu Financial LLC | 54,568 | $24.0K | 0.00% |
| UBS Group AG | 10,782 | $5.00K | 0.00% |
| Millennium Management LLC | 10,031 | $4.00K | 0.00% |
| FMR LLC | 5,168 | $2.00K | 0.00% |
Sold out (2)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Armistice Capital, LLC | 1,244,175 | $933.0K |
| Citigroup Inc | 6,650 | $5.00K |